Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential…
Management to Showcase New Nature-Cide Rat and Mouse Repellent Pouches Alongside Broader Nature-Cide Product Portfolio at Leading Industry Conference LOS…
MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is…
ZURICH, SWITZERLAND / ACCESSWIRE / October 21, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or…
Report Cites Projections of an Additional $3.5 Billion Upon Global Expansion STUART, Fla., Oct. 21, 2024 /PRNewswire/ -- Base Molecular…
STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report…
Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of…
LUND, SE / ACCESSWIRE / October 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) In accordance with the instructions to the nomination…
GENEVA, SWITZERLAND / ACCESSWIRE / October 21, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a…